175 related articles for article (PubMed ID: 35764877)
1. Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?
Damato BE
Eye (Lond); 2023 Apr; 37(5):830-836. PubMed ID: 35764877
[TBL] [Abstract][Full Text] [Related]
2. The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?
Flanagan JP; O'Day RF; Roelofs KA; McGuinness MB; van Wijngaarden P; Damato BE
Clin Exp Optom; 2023 Apr; 106(3):271-275. PubMed ID: 35156536
[TBL] [Abstract][Full Text] [Related]
3. Estimating malignancy risk of melanocytic choroidal tumours detected in the Australian National Eye Health Survey.
Salehi O; van Wijngaarden P; Keel S; Foreman J; Dirani M; Damato B; O'Day R
Clin Exp Optom; 2021 Nov; 104(8):854-858. PubMed ID: 33689655
[No Abstract] [Full Text] [Related]
4. Real-world experience of implementing the MOLES score in a virtual choroidal naevi clinic at a tertiary referral centre.
Rees NOT; Schimansky S; Bizley G; Kobayter L
Eye (Lond); 2024 Apr; 38(6):1183-1188. PubMed ID: 38057559
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.
Al Harby L; Sagoo MS; O'Day R; Hay G; Arora AK; Keane PA; Cohen VM; Damato B
Ocul Oncol Pathol; 2021 Sep; 7(4):294-302. PubMed ID: 34604203
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic naevi clustered on normal background skin.
Torchia D
Clin Exp Dermatol; 2015 Apr; 40(3):231-7. PubMed ID: 25703021
[TBL] [Abstract][Full Text] [Related]
7. Choroidal Nevus Features Associated with Subspecialty Referral.
Qureshi MB; Lentz PC; Xu TT; White LJ; Olsen TW; Pulido JS; Dalvin LA
Ophthalmol Retina; 2023 Dec; 7(12):1097-1108. PubMed ID: 37517800
[TBL] [Abstract][Full Text] [Related]
8. Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma.
Marks R; Dorevitch AP; Mason G
Australas J Dermatol; 1990; 31(2):77-80. PubMed ID: 2095738
[TBL] [Abstract][Full Text] [Related]
9. Ocular pigmented findings in patients with dysplastic naevus syndrome.
Toth-Molnar E; Olah J; Dobozy A; Hammer H
Melanoma Res; 2004 Feb; 14(1):43-7. PubMed ID: 15091193
[TBL] [Abstract][Full Text] [Related]
10. The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?
Roelofs KA; O'Day R; Harby LA; Arora AK; Cohen VML; Sagoo MS; Damato B
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455720
[TBL] [Abstract][Full Text] [Related]
11. Is Tumour Thickness Measurement Required for MOLES Scoring of Melanocytic Choroidal Tumours?
Ching J; AlHarby L; Sagoo MS; Damato B
Ocul Oncol Pathol; 2023 Aug; 9(1-2):40-47. PubMed ID: 38376089
[TBL] [Abstract][Full Text] [Related]
12. 'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.
Koh U; Janda M; Aitken JF; Duffy DL; Menzies S; Sturm RA; Schaider H; Betz-Stablein B; Prow T; Soyer HP; Green AC
BMJ Open; 2018 Sep; 8(9):e025857. PubMed ID: 30232117
[TBL] [Abstract][Full Text] [Related]
13. Melanocytic naevi, melanocytomas and emerging concepts.
Yeh I
Pathology; 2023 Mar; 55(2):178-186. PubMed ID: 36642570
[TBL] [Abstract][Full Text] [Related]
14. Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment.
Al Harby L; Ali Z; Rajai A; Roberts SA; Peto T; Leung I; Gray J; Hay G; Arora AK; Keane PA; Cohen VML; Sagoo M; Balaskas K
Br J Ophthalmol; 2022 Jan; 106(1):128-134. PubMed ID: 33037007
[TBL] [Abstract][Full Text] [Related]
15. The advantages of intermediate-tier, inter-optometric referral of low risk pigmented lesions.
Ly A; Nivison-Smith L; Hennessy M; Kalloniatis M
Ophthalmic Physiol Opt; 2017 Nov; 37(6):661-668. PubMed ID: 29044669
[TBL] [Abstract][Full Text] [Related]
16. Fundus autofluorescence of choroidal nevus and melanoma.
Lavinsky D; Belfort RN; Navajas E; Torres V; Martins MC; Belfort R
Br J Ophthalmol; 2007 Oct; 91(10):1299-302. PubMed ID: 17431017
[TBL] [Abstract][Full Text] [Related]
17. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
Lindelöf B; Hedblad MA; Sigurgeirsson B
Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
[TBL] [Abstract][Full Text] [Related]
18. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract][Full Text] [Related]
19. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
Schöniger S; Summers BA
Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
[TBL] [Abstract][Full Text] [Related]
20. Defining the Molecular Genetics of Dermoscopic Naevus Patterns.
Tan JM; Tom LN; Soyer HP; Stark MS
Dermatology; 2019; 235(1):19-34. PubMed ID: 30332666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
